Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -35.99-579.49-62.36150.21-353.26

What is the latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL is -35.99 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-35.99
Mar2023-579.49
Mar2022-62.36
Mar2021150.21
Mar2020-353.26

How is Core EBITDA Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Growth % Change
Mar2024 -35.99
Negative
Mar2023 -579.49
Negative
Mar2022 -62.36
Negative
Mar2021 150.21
Positive
Mar2020 -353.26 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹314.7 Cr 10.5% 8.3% 111.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,725.0 Cr 2.5% 0.2% 17.2% Stock Analytics
DIVIS LABORATORIES ₹159,525.0 Cr 2.1% 3.7% 66.4% Stock Analytics
CIPLA ₹123,206.0 Cr 0.9% 0.1% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,519.0 Cr -0.6% 0.4% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,927.5 Cr -0.3% -2.2% -0.1% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

10.5%

8.3%

111.2%

SENSEX

0.8%

3.8%

8.4%


You may also like the below Video Courses